等待开盘 08-25 09:30:00 美东时间
-0.560
-0.72%
作者:刘小雨、信心、陈建国 和君咨询医药医疗事业部 01 传统药企进军银发宠物经济的先天优势 ▶▷观点一:人药研发体系与质量标准可形成...
08-24 17:30
今日重点评级关注:康托·菲茨杰拉德:维持Ultragenyx Pharmaceutical"超配"评级,目标价从96美元升至103美元;Canaccord Genuity:维持Ultragenyx Pharmaceutical"买入"评级,目标价从81美元升至83美元
08-21 11:40
Stifel analyst Jonathan Block maintains Zoetis (NYSE:ZTS) with a Hold and lowers the price target from $85 to $80.
08-20 21:07
Analysts are intrested in these 5 stocks: ( ($ZTS) ), ( ($EPAM) ), ( ($DBX) ), ...
08-15 17:00
今日重点评级关注:HC Wainwright & Co.:维持Innate Pharma"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Immix Biopharma"买入"评级,目标价从20美元升至25美元
08-11 11:45
今日重点评级关注:康托·菲茨杰拉德:维持InflaRx"超配"评级,目标价从4美元升至6美元;RBC Capital:维持Nuvation Bio"跑赢大市"评级,目标价从19美元升至20美元
08-10 19:24
Major healthcare heavyweights, including Pfizer (PFE), Merck (MRK), and Eli Lilly (LLY), reported their quarterly earnings this week, pushing the healthcare sector into positive territory after five c...
08-08 23:15
JP Morgan analyst Chris Schott maintains Zoetis (NYSE:ZTS) with a Overweight and lowers the price target from $130 to $115.
08-08 02:28